DELPHARM SAINT REMY

𝐎𝐧 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 𝟏𝟐, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐄𝐩𝐢𝐥𝐞𝐩𝐬𝐲 𝐃𝐚𝐲, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦𝐬 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐚𝐥𝐥 𝐩𝐞𝐨𝐩𝐥𝐞 𝐰𝐢𝐭𝐡 𝐞𝐩𝐢𝐥𝐞𝐩𝐬𝐲. Affecting 50 million people worldwide, epilepsy is one of the most widespread neurological disorders. Some studies put the proportion of people with epilepsy who could live seizure-free if correctly diagnosed and treated at 70%, a statistic which proves that every effort must be made to diagnose and treat patients correctly. #Delpharm understands this need and would like to thank DELPHARM BRÉTIGNY, DELPHARM ORLEANS and DELPHARM LILLE for their ongoing efforts in the production of anti-epileptic treatment. Improving the health and quality of life of those affected is our priority.  #healthcare #cdmo

𝐎𝐧 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲 𝟒, 𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐚𝐲, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐰𝐨𝐮𝐥𝐝 𝐥𝐢𝐤𝐞 𝐭𝐨 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐚𝐟𝐟𝐞𝐜𝐭𝐞𝐝 𝐛𝐲 𝐜𝐚𝐧𝐜𝐞𝐫. Today, one in every six deaths is attributed to a form of cancer, making it one of the world's leading causes of death. Cancer must be fought with strength, and #Delpharm and its associates have understood this and are striving to bring solutions to the patients affected. Delpharm would like to thank DELPHARM LILLE for its contribution to the production of treatments for prostate, breast and leukemia cancers. As well as DELPHARM NOVARA site for its contribution to cancer treatments and DELPHARM MEPPEL for the production of treatment for acute myeloid leukemia. Improving the health and quality of life of cancer patients is our priority. #CDMO #healthcare

DELPHARM LILLE, 𝐲𝐨𝐮𝐫 𝐞𝐱𝐩𝐞𝐫𝐭 𝐢𝐧 𝐡𝐨𝐫𝐦𝐨𝐧𝐞 𝐭𝐚𝐛𝐥𝐞𝐭𝐬 For decades, the Lille site has been supporting you in the manufacture and packaging of hormonal tablets. To continue to meet your needs, #Delpharm has invested in a new state-of-the-art fully automatic PVC-ALU blister packaging line, with serialization and aggregation online. This line can be customized according to your requirements such as complex packaging items (calendar, pockets) or multi-phase filling with different tablets in the same blister. For more information contact us here: https://lnkd.in/dwn_qsp #healthcare #investing

#Delpharm #icionrecrute #alternance #QVT

Retour en images sur la journée de Noël des salariés de Delpharm St Rémy. Merci à Osmose-company.fr pour ses tours incroyablement magiques. 🪄 Toutes les équipes de Delpharm St Rémy vous souhaitent d’excellentes fêtes de fin d’année ! 🎊 🍾 🥂 #Delpharm #QVT #Recrutement #Noel

𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐢𝐬 𝐩𝐥𝐞𝐚𝐬𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐞 𝐚𝐩𝐩𝐨𝐢𝐧𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 Thomas Germain 𝐚𝐬 𝐂𝐡𝐢𝐞𝐟 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐎𝐟𝐟𝐢𝐜𝐞𝐫. Prior to joining #Delpharm, he was the CFO of listed French family-owned industrial group. Throughout close to 20 years in manufacturing companies, he brings his experience in international environments in our journey towards financial excellence started by Charles Gaudin some years ago. #healthcare #cdmo

🛠️ 𝐋𝐚 𝐦𝐚𝐢𝐧𝐭𝐞𝐧𝐚𝐧𝐜𝐞 𝐝𝐞𝐬 𝐔𝐭𝐢𝐥𝐢𝐭𝐞́𝐬 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐪𝐮𝐞𝐬 𝐞𝐬𝐭 𝐜𝐫𝐮𝐜𝐢𝐚𝐥𝐞 𝐩𝐨𝐮𝐫 𝐠𝐚𝐫𝐚𝐧𝐭𝐢𝐫 𝐥𝐚 𝐪𝐮𝐚𝐥𝐢𝐭𝐞́ 𝐞𝐭 𝐥𝐚 𝐬𝐞́𝐜𝐮𝐫𝐢𝐭𝐞́ 𝐝𝐞𝐬 𝐦𝐞́𝐝𝐢𝐜𝐚𝐦𝐞𝐧𝐭𝐬. 💡🤔𝐋𝐞 𝐬𝐚𝐯𝐢𝐞𝐳 𝐯𝐨𝐮𝐬 ❓🤔💡 Il existe 𝐝𝐞𝐮𝐱 𝐟𝐨𝐫𝐦𝐞𝐬 𝐝'𝐔𝐭𝐢𝐥𝐢𝐭𝐞́𝐬 en industrie pharmaceutique 🤍𝐥𝐞𝐬 𝐔𝐭𝐢𝐥𝐢𝐭𝐞́𝐬 𝐏𝐫𝐨𝐩𝐫𝐞𝐬 sont les systèmes et ressources qui 𝐢𝐧𝐭𝐞𝐫𝐚𝐠𝐢𝐬𝐬𝐞𝐧𝐭 𝐝𝐢𝐫𝐞𝐜𝐭𝐞𝐦𝐞𝐧𝐭 𝐚𝐯𝐞𝐜 𝐥𝐞 𝐩𝐫𝐨𝐝𝐮𝐢𝐭 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐪𝐮𝐞 𝐨𝐮 𝐥𝐞𝐬 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐮𝐬 𝐜𝐫𝐢𝐭𝐢𝐪𝐮𝐞𝐬, et doivent donc respecter des normes de qualité extrêmement strictes pour éviter toute contamination: 𝐄𝐚𝐮 𝐩𝐮𝐫𝐢𝐟𝐢𝐞́𝐞💧, 𝐄𝐏𝐏𝐈💧, 𝐕𝐚𝐩𝐞𝐮𝐫 𝐩𝐮𝐫𝐞♨️, 𝐀𝐢𝐫 𝐜𝐨𝐦𝐩𝐫𝐢𝐦𝐞́ 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐪𝐮𝐞💨, 𝐠𝐚𝐳 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐪𝐮𝐞𝐬🫧, 𝐒𝐲𝐬𝐭𝐞̀𝐦𝐞𝐬 𝐇𝐕𝐀𝐂🎛️ (salles blanches)... 🩶𝐥𝐞𝐬 𝐔𝐭𝐢𝐥𝐢𝐭𝐞́𝐬 𝐆𝐫𝐢𝐬𝐞𝐬 désignent les systèmes et infrastructures techniques qui 𝐬𝐨𝐮𝐭𝐢𝐞𝐧𝐧𝐞𝐧𝐭 𝐢𝐧𝐝𝐢𝐫𝐞𝐜𝐭𝐞𝐦𝐞𝐧𝐭 𝐥𝐞𝐬 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐮𝐬 𝐝𝐞 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧, sans entrer en contact direct avec le produit final: 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐝𝐞 𝐯𝐚𝐩𝐞𝐮𝐫 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐥𝐥𝐞♨️, 𝐒𝐲𝐬𝐭𝐞̀𝐦𝐞𝐬 𝐝𝐞 𝐫𝐞𝐟𝐫𝐨𝐢𝐝𝐢𝐬𝐬𝐞𝐦𝐞𝐧𝐭❄️, 𝐒𝐲𝐬𝐭𝐞̀𝐦𝐞𝐬 𝐇𝐕𝐀𝐂🎛️, 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐝'𝐚𝐢𝐫 𝐜𝐨𝐦𝐩𝐫𝐢𝐦𝐞́ 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐥💨, 𝐓𝐫𝐚𝐢𝐭𝐞𝐦𝐞𝐧𝐭 𝐝𝐞𝐬 𝐞𝐚𝐮𝐱 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐥𝐥𝐞𝐬♻️ ... 🦾𝐔𝐧𝐞 𝐦𝐚𝐢𝐧𝐭𝐞𝐧𝐚𝐧𝐜𝐞 𝐨𝐩𝐭𝐢𝐦𝐚𝐥𝐞 assure que ces équipements fonctionnent conformément aux normes strictes des BPF, d'éviter les contaminations, les arrêts de production imprévus et tout autre évènement pouvant affecter la 𝐪𝐮𝐚𝐥𝐢𝐭𝐞́ du produit final et la 𝐬𝐞́𝐜𝐮𝐫𝐢𝐭𝐞́ des opérateurs et des patients.💚 C'est pourquoi 📍DELPHARM DIJON (https://lnkd.in/e3-3TDyZ), 📍DELPHARM SAINT REMY (https://lnkd.in/eZjKnwya) et 📍DELPHARM TOURS (https://lnkd.in/emjpBfZ5), 3 sites de production de formes essentiellement injectables💉, recherchent 𝐝𝐞𝐬 𝐄𝐱𝐩𝐞𝐫𝐭(𝐞)𝐬 𝐝𝐞 𝐥𝐚 𝐌𝐚𝐢𝐧𝐭𝐞𝐧𝐚𝐧𝐜𝐞 𝐝𝐞𝐬 𝐔𝐭𝐢𝐥𝐢𝐭𝐞́𝐬🔧 pour garantir la 𝐝𝐢𝐬𝐩𝐨𝐧𝐢𝐛𝐢𝐥𝐢𝐭𝐞́, 𝐥'𝐨𝐩𝐞́𝐫𝐚𝐭𝐢𝐨𝐧𝐧𝐚𝐥𝐢𝐭𝐞́ 𝐞𝐭 𝐥𝐚 𝐟𝐢𝐚𝐛𝐢𝐥𝐢𝐭𝐞́ 🎯de ses exploitations et œuvrer à 𝐠𝐚𝐫𝐚𝐧𝐭𝐢𝐫 𝐧𝐨𝐭𝐫𝐞 𝐚𝐦𝐛𝐢𝐭𝐢𝐨𝐧 "𝐀𝐦𝐞́𝐥𝐢𝐨𝐫𝐞𝐫 𝐥𝐚 𝐯𝐢𝐞 𝐝𝐞𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐞𝐧 𝐫𝐞𝐧𝐟𝐨𝐫𝐜̧𝐚𝐧𝐭 𝐥𝐚 𝐬𝐚𝐭𝐢𝐬𝐟𝐚𝐜𝐭𝐢𝐨𝐧 𝐝𝐞 𝐧𝐨𝐬 𝐜𝐥𝐢𝐞𝐧𝐭𝐬"⚕️ 🔜Rejoignez nous et "𝐄𝐧𝐬𝐞𝐦𝐛𝐥𝐞, 𝐃𝐞́𝐯𝐞𝐥𝐨𝐩𝐩𝐨𝐧𝐬 𝐧𝐨𝐭𝐫𝐞 𝐀𝐯𝐞𝐧𝐢𝐫"🌱 #CDMO #pharmaceutique #icicarecrute #iciçarecrute #maintenance #utilités #utilitespropres #utilitesgrises #cleanutilities #grayutilities #genieclimatique #geniethermique #geniechimique

𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦, 𝐲𝐨𝐮𝐫 𝐞𝐱𝐩𝐞𝐫𝐭 𝐢𝐧 𝐧𝐚𝐬𝐚𝐥 𝐬𝐩𝐫𝐚𝐲𝐬 Delpharm Montréal is your next center of excellence for nasal sprays. This site fills and packages plastic or glass nasal sprays for the whole world. With a high speed line fully automated, Delpharm Montreal will handle high volume in sizes ranging from 5 to 45 ml. Others sizes would be available soon. 👉 Contact us for more information https://lnkd.in/dwn_qsp

𝐓𝐨 𝐦𝐚𝐫𝐤 𝐭𝐡𝐞 𝐦𝐨𝐧𝐭𝐡 𝐨𝐟 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫, 𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐰𝐨𝐮𝐥𝐝 𝐥𝐢𝐤𝐞 𝐭𝐨 𝐫𝐞𝐚𝐟𝐟𝐢𝐫𝐦 𝐢𝐭𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐚𝐥𝐥 𝐦𝐞𝐧 𝐬𝐮𝐟𝐟𝐞𝐫𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫. Prostate cancer is the most common male cancer in 96 countries, so access to effective treatment is vital to ensure that patients receive the best possible care. #Delpharm is mobilized for this cause, and would like to thank the DELPHARM LILLE and Delpharm Novara sites for their commitment to the production of prostate cancer treatments. Moreover, during this month, Delpharm employees have been made aware of this disease through conferences. 𝐼𝘮𝑝𝘳𝑜𝘷𝑖𝘯𝑔 𝑝𝘢𝑡𝘪𝑒𝘯𝑡𝘴' ℎ𝘦𝑎𝘭𝑡𝘩 𝘢𝑛𝘥 𝘲𝑢𝘢𝑙𝘪𝑡𝘺 𝘰𝑓 𝑙𝘪𝑓𝘦 𝘪𝑠 𝑜𝘶𝑟 𝑝𝘳𝑖𝘰𝑟𝘪𝑡𝘺. #healthcare #movember #cdmo

𝐃𝐞𝐥𝐩𝐡𝐚𝐫𝐦 𝐬𝐞𝐜𝐮𝐫𝐞𝐬 𝐜𝐨𝐫𝐭𝐢𝐜𝐨𝐢𝐝𝐬 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐢𝐧 𝐅𝐫𝐚𝐧𝐜𝐞. Today, #Delpharm has inaugurated a new, fully automated, high-speed packaging line at DELPHARM LILLE to improve the availability of corticoids for French patients.   As part of a strategy to modernise the site, an investment of €5.3 million has been approved, supported by the French government through the ‘France Relance’ investment programme, which has authorised Bpifrance to grant Delpharm a subsidy of €3.6 million.    By increasing its capacity from 8 to 20 million boxes a year, Delpharm will secure availability of corticoids for French patients.   Delpharm continues its commitment to French’s healthcare sovereignty. #investing #francerelance #cdmo